Post #2859221

RE: https://tomkahe.com/@GiftArticles/116614848032470325 “A suite of four new studies suggest that people taking so-called GLP-1 drugs like Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro saw reductions in tumor progression, lower overall chance of death and less risk of developing breast cancer. “It’s really provocative that they showed, in several cancers, that people who took these drugs seem to have a lower risk of their cancer returning,”“ #Cancer #GLP1